121 related articles for article (PubMed ID: 15823792)
41. Absence of estrogen receptors in dysplastic nevi and malignant melanoma.
Lecavalier MA; From L; Gaid N
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):242-6. PubMed ID: 2212119
[TBL] [Abstract][Full Text] [Related]
42. Basaloid neoplasms in nevus sebaceus.
Kaddu S; Schaeppi H; Kerl H; Soyer HP
J Cutan Pathol; 2000 Aug; 27(7):327-37. PubMed ID: 10917159
[TBL] [Abstract][Full Text] [Related]
43. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P
Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
[TBL] [Abstract][Full Text] [Related]
44. Melanocytic activation in HIV-1 disease: HMB-45 staining in common acquired nevi. Military Medical Consortium for the Advancement of Retroviral Research.
Smith KJ; Skelton HG; Heimer W; Baxter D; Angritt P; Frisman D; Wagner KF
J Am Acad Dermatol; 1993 Oct; 29(4):539-44. PubMed ID: 7691905
[TBL] [Abstract][Full Text] [Related]
45. The spectrum of dermatoscopic patterns in blue nevi.
Di Cesare A; Sera F; Gulia A; Coletti G; Micantonio T; Fargnoli MC; Peris K
J Am Acad Dermatol; 2012 Aug; 67(2):199-205. PubMed ID: 22030018
[TBL] [Abstract][Full Text] [Related]
46. Localization of MGSA/GRO protein in cutaneous lesions.
Tettelbach W; Nanney L; Ellis D; King L; Richmond A
J Cutan Pathol; 1993 Jun; 20(3):259-66. PubMed ID: 8366215
[TBL] [Abstract][Full Text] [Related]
47. Paradigmatic cases of pigmented lesions: How to not miss melanoma.
Farnetani F; Scope A; Coco V; Guida S; Cesinaro AM; Piana S; Peris K; Pellacani G; Longo C
J Dermatol; 2016 Dec; 43(12):1433-1437. PubMed ID: 27402032
[TBL] [Abstract][Full Text] [Related]
48. The use of elastin immunostain improves the evaluation of melanomas associated with nevi.
Kamino H; Tam S; Tapia B; Toussaint S
J Cutan Pathol; 2009 Aug; 36(8):845-52. PubMed ID: 19032378
[TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness.
Bayer-Garner IB; Hough AJ; Smoller BR
Mod Pathol; 1999 Aug; 12(8):770-4. PubMed ID: 10463478
[TBL] [Abstract][Full Text] [Related]
50. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions.
Prieto VG; McNutt NS; Lugo J; Reed JA
J Cutan Pathol; 1997 Mar; 24(3):145-50. PubMed ID: 9085149
[TBL] [Abstract][Full Text] [Related]
51. The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions.
Kazakov DV; Kutzner H; Rütten A; Michal M; Requena L; Burg G; Dummer R; Kempf W
Am J Dermatopathol; 2004 Apr; 26(2):102-7. PubMed ID: 15024190
[TBL] [Abstract][Full Text] [Related]
52. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer.
Kennedy C; Bajdik CD; Willemze R; De Gruijl FR; Bouwes Bavinck JN;
J Invest Dermatol; 2003 Jun; 120(6):1087-93. PubMed ID: 12787139
[TBL] [Abstract][Full Text] [Related]
53. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
54. Expression of the nm23 metastasis-suppressor gene product in skin tumors.
Kanitakis J; Euvrard S; Bourchany D; Faure M; Claudy A
J Cutan Pathol; 1997 Mar; 24(3):151-6. PubMed ID: 9085150
[TBL] [Abstract][Full Text] [Related]
55. Unscheduled Visits of Patients with Familial Melanoma to a Pigmented Lesion Clinic: Evaluation of Patients' Characteristics and Suspicious Lesions.
Nabil R; Plasmeijer E; van Doorn R; Bergman W; Kukutsch NA
Acta Derm Venereol; 2018 Jul; 98(7):667-670. PubMed ID: 29542807
[TBL] [Abstract][Full Text] [Related]
56. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
van Kempen LC; van den Oord JJ; van Muijen GN; Weidle UH; Bloemers HP; Swart GW
Am J Pathol; 2000 Mar; 156(3):769-74. PubMed ID: 10702391
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.
van den Oord JJ; Maes A; Stas M; Nuyts J; De Wever I; De Wolf-Peeters C
Melanoma Res; 1997 Apr; 7(2):121-8. PubMed ID: 9167178
[TBL] [Abstract][Full Text] [Related]
58. Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions.
Fogt F; Vortmeyer AO; Tahan SR
Am J Dermatopathol; 1995 Feb; 17(1):12-7. PubMed ID: 7695006
[TBL] [Abstract][Full Text] [Related]
59. Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis.
Pizzichetta MA; Kittler H; Stanganelli I; Bono R; Cavicchini S; De Giorgi V; Ghigliotti G; Quaglino P; Rubegni P; Argenziano G; Talamini R;
Br J Dermatol; 2015 Jul; 173(1):106-14. PubMed ID: 25916655
[TBL] [Abstract][Full Text] [Related]
60. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions.
Wang H; Shen SS; Wang H; Diwan AH; Zhang W; Fuller GN; Prieto VG
J Cutan Pathol; 2003 Nov; 30(10):599-605. PubMed ID: 14744083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
